AbbVie Long Term Debt 2010-2024 | ABBV

AbbVie long term debt for the quarter ending September 30, 2024 was $58.509B, a 5.17% increase year-over-year.

  • AbbVie long term debt for 2023 was $52.194B, a 11.74% decline from 2022.
  • AbbVie long term debt for 2022 was $59.135B, a 7.87% decline from 2021.
  • AbbVie long term debt for 2021 was $64.189B, a 17.23% decline from 2020.

AbbVie Long Term Debt 2010-2024 | ABBV

  • AbbVie long term debt for 2023 was $52.194B, a 11.74% decline from 2022.
  • AbbVie long term debt for 2022 was $59.135B, a 7.87% decline from 2021.
  • AbbVie long term debt for 2021 was $64.189B, a 17.23% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B